Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway.
Biomed Pharmacother. 2019 Sep;117:109088. doi: 10.1016/j.biopha.2019.109088. Epub 2019 Jun 12.
Biomed Pharmacother. 2019.
PMID: 31202173
Free article.